Manfred Kaufmann

Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes

Gϋnter von Minckwitz, Michael Untch, Jens‐Uwe Blohmer et al. · Journal of Clinical Oncology · 2012 · 2.7K citations

Medicine, Oncology, Breast Oncology +15

2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial

Ian Smith, Marion Procter, Richard D. Gelber et al. · The Lancet · 2007 · 1.5K citations

Medicine, Oncology, Breast Oncology +15

Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial

R. Jakesz, W. Jonat, Michael Gnant et al. · The Lancet · 2005 · 876 citations

Medicine, Endocrinology, Oncology +15

Reduction in New Metastases in Breast Cancer with Adjuvant Clodronate Treatment

Ingo Diel, Erich‐Franz Solomayer, Serban Dan Costa et al. · New England Journal of Medicine · 1998 · 812 citations · Full text

Medicine, Oncology, Pharmacology +16

A New Molecular Predictor of Distant Recurrence in ER-Positive, HER2-Negative Breast Cancer Adds Independent Information to Conventional Clinical Risk Factors

Martin Filipits, Margaretha Rudas, R. Jakesz et al. · Clinical Cancer Research · 2011 · 728 citations · Full text

Medicine, Cancer Biology, Oncology +17